超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

艾伯維  AbbVie  
 雅培（Abbott） 將品牌藥業務拆分組建新公司Abbvie的計劃。Abbvie將作為一個獨立的公司，于2013年1月2日在紐約證券交易所交易，股票符號為ABBV。雅培將保留其醫療設備、診斷、營養品業務，以及專利到期的藥物

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and capabilities of a long-established pharmaceutical leader to develop and market advanced therapies that address some of the world’s most complex and serious diseases. In 2013, AbbVie will employ approximately 21,000 people worldwide and markets medicines in more than 170 countries.